Clinical Trials Browser

Phase 1/2 × Ovarian Neoplasms × anlotinib × Clear all

NCT02558348 2019-06-19

AL3818

Phase 1/2 Terminated

Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms